Decade Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
BIT
Decade Capital Management's VRTX Position: Q3 2015 in Review
Decade Capital Management reduced its Vertex Pharmaceuticals (VRTX) stake by 74% in Q3 2015, selling an estimated $6.41M and leaving 17,601 shares worth $1.83M. The position accounts for 0.4% of the portfolio, ranked #65.
Decade Capital Management first reported a position in VRTX in Q1 2015 and has held it in 3 quarters since. The position peaked at $8.85M in Q1 2015. 493 funds tracked by Wall St. Rank hold VRTX as of Q3 2015.
- Decade Capital Management held 17,601 shares of Vertex Pharmaceuticals worth $1.83M as of Q3 2015.
- Decade Capital Management sold 49,893 Vertex Pharmaceuticals shares in Q3 2015, an estimated $6.41M.
- Vertex Pharmaceuticals made up 0.4% of Decade Capital Management's portfolio in Q3 2015, its #65 holding.
- Decade Capital Management first reported a position in Vertex Pharmaceuticals in Q1 2015 and has held it in 3 quarters since.
- Decade Capital Management's Vertex Pharmaceuticals position peaked at $8.85M in Q1 2015.
- 493 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2015.
Based on Decade Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.